Biology Reference
In-Depth Information
healthy volunteers.
Blood
76: 1718-1722
16 Jensen JD, Madsen JK, Jensen LW, Pedersen EB (1994) Pharmacokinetics of epoetin in dialysis
patients before and after correction of the anaemia.
Drug Investigation
8: 278-287
17 Jensen JD, Jensen LW, Madsen JK, Poulsen L (1995) The metabolism of erythropoietin in liver
cirrhosis patients compared with healthy volunteers.
Eur J Haematol
54: 111-116
18 Jensen JD, Madsen JK, Jensen LW, Pedersen EB (1994) Reduced production, absorption, and
elimination of erythropoietin in uremia compared with healthy volunteers.
J Am Soc Nephrol
5:
177-185
19 Veng-Pedersen P, Widness JA, Pereira LM, Peters C, Schmidt RL, Lowe LS (1995) Kinetic eval-
uation of nonlinear drug elimination by a disposition decomposition analysis. Application to the
analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.
J Pharm Sci
84:
760-767
20 Salmonson T, Danielson BG, Wikstrom B (1990) The pharmacokinetics of recombinant human
erythropoietin after intravenous and subcutaneous administration to healthy subjects.
Br J Clin
Pharmacol
29: 709-713
21 Souillard A, Audran M, Bressolle F, Gareau R, Duvallet A, Chanal JL (1996) Pharmacokinetics
and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and
doping control.
Br J Clin Pharmacol
42: 355-364
22 Sans T, Joven J, Vilella E, Masdeu G, Farre M (2000) Pharmacokinetics of several subcutaneous
doses of erythropoietin: potential implications for blood transfusion.
Clin Exp Pharmacol Physiol
27: 179-184
23Hayashi N, Kinoshita H, Yukawa E, Higuchi S (1998) Pharmacokinetic analysis of subcutaneous
erythropoeitin administration with nonlinear mixed effect model including endogenous produc-
tion.
Br J Clin Pharmacol
46: 11-19
24Kindler J, Eckardt KU, Ehmer B, Jandeleit K, Kurtz A, Schreiber A, Scigalla P, Sieberth HG
(1989) Single-dose pharmacokinetics of recombinant human erythropoietin in patients with vari-
ous degrees of renal failure.
Nephrol Dial Transplant
4: 345-349
25 Neumayer HH, Brockmöller J, Fritschka E, Roots I, Scigalla P, Wattenberg M, (1989)
Pharmacokinetics of recombinant human erythropoietin after SC administration and in long-term
IV treatment in patients on maintenance hemodialysis.
Contrib Nephrol
76: 131-141
26 Macdougall IC, Roberts DE, Neubert P, Dharmasena AD, Coles GA, Williams JD (1989)
Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory
peritoneal dialysis.
Lancet
1: 425-427
27 Hughes RT, Cotes PM, Oliver DO, Pippard MJ, Royston P, Stevens JM, Strong CA, Tam RC
(1989) Correction of the anaemia of chronic renal failure with erythropoietin: Pharmacokinetic
studies in patients on haemodialysis and CAPD.
Contrib Nephrol
76: 122-130
28Egrie JC, Eschbach JW, McGuire T, Adamson JW (1988) Pharmacokinetics of recombinant
human erythropoietin (rHuEpo) administered to hemodialysis (HD) patients.
Kidney Int
33:
abstract, p. 262
29 Cotes JM, Pippard MJ, Reid CD, Winearls CG, Oliver DP, Royston JP (1989) Characterization of
the anaemia of chronic renal failure and the mode of its correction by a preparation of human ery-
thropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin
and its effects on erythrokinetics.
Q J Med
70:113-137
30 Kampf D, Kahl A, Passlick J, Pustelnik A, Eckardt KU, Ehmer B, Jacobs C, Baumelou A,
Grabensee B, Gahl GM (1989) Single-dose kinetics of recombinant human erythropoietin after
intravenous,
subcutaneous and intraperitoneal administration. Preliminary results.
Contrib
Nephrol
76:106-110
31 Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry P, Fangman J (1989) Recombinant
human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial.
Ann Intern Med
110: 108-114
32 Krömer G, Solf A, Ehmer B, Kaufmann B, Quellhorst E (1990) Single dose pharmacokinetics of
recombinant human erythropoietin (rhEPO) comparing intravenous (IV), subcutaneous (SC) and
intraperitoneal (IP) administration in ipd patients.
Kidney Int
37: 331
33 Stockenhuber F, Loibl U, Gottsauner-Wolf M, Jahn C, Manker W, Meisl TF, Balcke (1991)
Pharmacokinetics and dose response after intravenous and subcutaneous administration of recom-
binant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory
peritoneal dialysis.
Nephron
59:399-402
34 Yamazaki C, Watanabe Y, Sakamoto N (1993) Pharmacokinetic study of recombinant human ery-
